Comparing MTT and Dye Exclusion Assays for Childhood Leukaemia
Author Information
Author(s): R. Pieters, D.R. Huismans, A. Leyva, A.J.P. Veerman
Primary Institution: Free University Hospital
Hypothesis
The MTT assay can be effectively adapted for testing leukaemic samples and should yield results comparable to the dye exclusion assay.
Conclusion
The MTT assay is more efficient and less prone to observer error compared to the dye exclusion assay for assessing chemosensitivity in childhood leukaemia.
Supporting Evidence
- The MTT assay showed a good correlation with the DEA in drug sensitivity testing.
- The MTT assay is much more efficient, requiring only 15 minutes of technician time after incubation.
- Both assays were technically successful in 7 out of 10 patients.
Takeaway
Scientists tested two methods to see how well they can find out if cancer treatments work for kids with leukaemia. One method was faster and easier to use.
Methodology
The study compared the MTT assay and dye exclusion assay (DEA) for drug sensitivity testing using leukaemic samples from children.
Potential Biases
Observer error may affect the results of the dye exclusion assay.
Limitations
The study had a small sample size and some assays were technically unsuccessful.
Participant Demographics
Children with acute lymphoblastic leukaemia and one with chronic myeloid leukaemia.
Want to read the original?
Access the complete publication on the publisher's website